InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Karen A Dawes, Director, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 11 open-market SEC Form 4 transactions: 0 purchases worth $0 and 11 sales worth $4.9M, reported from Aug 17, 21 to Dec 17, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 17, 25 | RGENREPLIGEN CORP | SELL | 275 | $161.00 | $44K |
| Feb 27, 24 | RGENREPLIGEN CORP | SELL | 1.0K | $193.35 | $193K |
| Aug 29, 23 | RGENREPLIGEN CORP | SELL | 850 | $171.38 | $146K |
| Sep 9, 22 | RGENREPLIGEN CORP | SELL | 775 | $227.17 | $176K |
| May 25, 22 | RGENREPLIGEN CORP | SELL | 7.7K | $152.84 | $1.2M |
| Nov 10, 21 | RGENREPLIGEN CORP | SELL | 1.1K | $271.28 | $295K |
| Nov 2, 21 | RGENREPLIGEN CORP | SELL | 700 | $306.49 | $214K |
| Sep 14, 21 | RGENREPLIGEN CORP | SELL | 108 | $295.82 | $32K |
| Sep 1, 21 | RGENREPLIGEN CORP | SELL | 1.1K | $285.44 | $315K |
| Aug 18, 21 | RGENREPLIGEN CORP | SELL | 634 | $262.31 | $164K |
| Aug 17, 21 | RGENREPLIGEN CORP | SELL | 8.6K | $256.43 | $2.2M |